Unimedic AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Unimedic AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10929
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas which include anesthesiology or intensive care, gastroenterology, immunoglobulins or transplant, and drug addiction treatment. It also provides services including contract development, validation, chemical and microbiological analyses of active raw materials (API), excipients, water for injection (WFI) and finished products; performs stability studies; and formulation development from laboratory scale batches up to full scale batches. Unimedic also supplies imported pharmaceuticals to pharmacies; and provides repackaging services for medical products, dietary supplements, cosmetics or medical devices, and clinical trials. The company partners with academics, industry and the health care sectors. Unimedic is headquartered in Matfors, Sweden.

Unimedic AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Unimedic AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unimedic AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Unimedic Enters into Distribution Agreement with Mylan 10
Licensing Agreements 11
Unimedic Pharma Enters into Licensing Agreement with Basilea Pharma 11
Unimedic Enters into Licensing Agreement with Martindale Pharma 12
Acquisition 13
Unimedic Acquires Miwana 13
Unimedic Acquires Cross Pharma From Medivir For USD18.6 Million 14
Unimedic Acquires Pharmadone 15
Unimedic Acquires Ergobe Pharma 16
Unimedic AB – Key Competitors 17
Unimedic AB – Key Employees 18
Unimedic AB – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Unimedic AB, Pharmaceuticals & Healthcare, Key Facts 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Deals By Therapy Area, 2012 to YTD 2018 8
Unimedic AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unimedic Enters into Distribution Agreement with Mylan 10
Unimedic Pharma Enters into Licensing Agreement with Basilea Pharma 11
Unimedic Enters into Licensing Agreement with Martindale Pharma 12
Unimedic Acquires Miwana 13
Unimedic Acquires Cross Pharma From Medivir For USD18.6 Million 14
Unimedic Acquires Pharmadone 15
Unimedic Acquires Ergobe Pharma 16
Unimedic AB, Key Competitors 17
Unimedic AB, Key Employees 18
Unimedic AB, Subsidiaries 19

List of Figures
Unimedic AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Unimedic AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TMRC Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary TMRC Co Ltd (TMRC) is a biopharmaceutical company that develops and markets anti-cancer and cancer related products. The company’s products include tamibarotene Am-80, TOS-80T, OMS0728, and others. Its tamibarotene is a synthetic retinoid, which is designed to develop drug-able properties of …
  • Travelzest plc:企業の戦略・SWOT・財務分析
    Travelzest plc - Strategy, SWOT and Corporate Finance Report Summary Travelzest plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cyberonics, Inc. (CYBX):(医療機器分野)企業M&A及び提携動向
    Summary Cyberonics, Inc. (Cyberonics) is a medical technology company. The company designs, develops and markets medical devices for the treatment of epilepsy and other psychiatric diseases. It develops and markets vagus nerve stimulation (VNS) therapy system which is used in the treatment of refrac …
  • TransAlta Corporation:発電所・企業SWOT分析
    TransAlta Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Merrimack Pharmaceuticals Inc (MACK):医療機器:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …
  • Bartlett Cocke General Contractors:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Bartlett Cocke General Contractors" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric …
  • NetSol Technologies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NetSol Technologies, Inc. Merge …
  • BG Medicine, Inc. (BGMD):企業のM&A・提携動向(医療機器分野)
    Summary BG Medicine, Inc. (BGM) is a medical device company that discovers, develops and delivers diagnostic solutions to aid in the clinical management of heart failure and related disorders. The company offers test products which includes BGM Galectin-3. Its BGM Galectin-3 is a diagnostic test, wh …
  • Oman Oil Company S.A.O.C.:企業のM&A・提携動向(エネルギー分野)
    Summary Oman Oil Company S.A.O.C. (OOC) is an oil and gas service provider that offers investment facilities for the growth and development of energy sector. The company invests in the areas of exploration and production and related services, energy infrastructure and shipping, oil refining and mark …
  • SeraCare Life Sciences, Inc.:企業の戦略的SWOT分析
    SeraCare Life Sciences, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Actom (Pty) Ltd:企業のM&A・提携動向(エネルギー分野)
    Summary ACTOM (Pty) Ltd (ACTOM) is a power equipment manufacturing company. The company manufactures repairs and distributes electro-mechanical equipment. Its product categories include power conversion products, high voltage equipment, wilec & transwire, power transformers, and distribution transfo …
  • Interwaste Holdings Limitedの企業概要及び財務/SWOT分析
    Interwaste Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Interwaste Holdings Limited annual and quarterly forecasts made by stock market experts. The repor …
  • Galliford Try plc:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Galliford Try plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence …
  • TeleChoice International Ltd. (T41):企業財務及び戦略的SWOT分析
    Summary TeleChoice International Ltd. (TeleChoice) is a communication service provider that offers info-communications products and services. The company operates through three business such as personal communications solutions services ("PCS"), info-communications technology services ("ICT") and ne …
  • Peregrine Pharmaceuticals, Inc. (formerly Techniclone Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Peregrine Pharmaceuticals, Inc. …
  • Nobelpharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NobelPharma Co Ltd (NobelPharma) is a pharmaceutical company that develops medicines for rare diseases and unmet medical needs. The company’s pipeline products include NPC-09, NPC-12, NPC-15, NPC-16, NPC-17 and NPC-18. It offers products in the therapeutic areas of oncology, metabolic diseas …
  • Savanna Energy Services Corp. (SVY):企業概要、財務及び戦略的SWOT分析
    Summary Savanna Energy Services Corp. (Savanna) is an oil field services company. The company conducts conventional drilling, Hybrid drilling, and well servicing and comprehensive oilfield services such as oilfield equipment rental that meet the needs of oil and gas customer base. It provides drilli …
  • Creightons plc:企業の戦略・SWOT・財務情報
    Creightons plc - Strategy, SWOT and Corporate Finance Report Summary Creightons plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Concho Resources Inc (CXO):石油・ガス:M&Aディール及び事業提携情報
    Summary Concho Resources Inc (Concho) is an oil and gas company that acquires, develops and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in the US. Co …
  • Dynavax Technologies Corporation:企業のM&A・提携・投資分析
    Dynavax Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dynavax Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆